{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:49:30Z","timestamp":1754153370864,"version":"3.41.2"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1097\/igc.0b013e3182959053","type":"journal-article","created":{"date-parts":[[2013,6,7]],"date-time":"2013-06-07T07:09:39Z","timestamp":1370588979000},"page":"1044-1049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Risk of Subsequent Malignancies in Women With Uterine Papillary Serous or Clear Cell Endometrial Cancers"],"prefix":"10.1016","volume":"23","author":[{"given":"Hilary D.","family":"Hinshaw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashlee","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bunja","family":"Rungruang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Joseph L.","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushil","family":"Beriwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C.","family":"Krivak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paniti","family":"Sukumvanich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander B.","family":"Olawaiye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e3182959053_bb0005","unstructured":"Cancer Facts and Figures 2012. Atlanta, GA: American Cancer Society; 2012."},{"key":"10.1097\/IGC.0b013e3182959053_bb0010","doi-asserted-by":"crossref","first-page":"218.e1","DOI":"10.1016\/j.ajog.2007.08.075","article-title":"Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths","volume":"198","author":"Ueda","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1097\/IGC.0b013e3182959053_bb0015","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1200\/JCO.2006.06.7173","article-title":"Molecular and pathologic aspects of endometrial carcinogenesis","volume":"24","author":"Hecht","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1097\/IGC.0b013e3182959053_bb0020","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1006\/gyno.1999.5505","article-title":"Epidemiopathologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma","volume":"74","author":"Cirisano","year":"1999","journal-title":"Gynecol Oncol"},{"year":"2010","key":"10.1097\/IGC.0b013e3182959053_bb0025"},{"key":"10.1097\/IGC.0b013e3182959053_bb0030","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ygyno.2009.02.003","article-title":"Management of women with clear cell endometrial cancer","volume":"113","author":"Olawaiye","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1097\/IGC.0b013e3182959053_bb0035","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ygyno.2009.06.011","article-title":"Management of women with uterine papillary serous cancer","volume":"115","author":"Boruta","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1097\/IGC.0b013e3182959053_bb0040","first-page":"S105YS143","article-title":"Carcinoma of the corpus uteri. FIGO 26th annual report on the results of treatment in gynecological cancer","volume":"95","author":"Creasman","year":"2006","journal-title":"Int J Gynecol Obstet"},{"key":"10.1097\/IGC.0b013e3182959053_bb0045","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/jnci\/djs345","article-title":"Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses","volume":"103","author":"Kuhn","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1097\/IGC.0b013e3182959053_bb0050","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1006\/gyno.2001.6445","article-title":"Papillary serous carcinoma of the uterus: increased risk of subsequent or concurrent development of breast carcinoma","volume":"83","author":"Geisler","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1097\/IGC.0b013e3182959053_bb0055","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/modpathol.3800057","article-title":"Molecular characterization of uterine clear cell carcinoma","volume":"17","author":"An","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1097\/IGC.0b013e3182959053_bb0060","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0046-8177(98)80002-6","article-title":"Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression","volume":"29","author":"Lax","year":"1998","journal-title":"Hum Pathol"},{"key":"10.1097\/IGC.0b013e3182959053_bb0065","unstructured":"National Cancer Institute (US). Overview of the SEER Program. Bethesda, MD: National Institutes of Health. Cited August 3, 2012. Available at: http:\/\/seer.cancer.gov\/about\/overview.html."},{"key":"10.1097\/IGC.0b013e3182959053_bb0070","unstructured":"National Cancer Institute (US). SEER Datasets & Software. Bethesda, MD: National Institutes of Health. Cited August 3, 2012. Available at: http:\/\/seer.cancer.gov\/resources\/index.html."},{"key":"10.1097\/IGC.0b013e3182959053_bb0075","unstructured":"National Cancer Institute (US). Multiple primaryYstandardized incidence ratios. Bethesda, MD: National Institutes of Health. Cited August 3, 2012. Available at: http:\/\/seer.cancer.gov\/seerstat\/mp-sir.html."},{"key":"10.1097\/IGC.0b013e3182959053_bb0080","unstructured":"National Cancer Institute (US). SEER*Stat Databases: November 2011 Submission. Bethesda, MD: National Institutes of Health. Cited August 3, 2012. Available at: http:\/\/seer.cancer.gov\/data\/seerstat\/nov2011\/."},{"year":"2001","key":"10.1097\/IGC.0b013e3182959053_bb0085"},{"key":"10.1097\/IGC.0b013e3182959053_bb0090","first-page":"337\u00c2","article-title":"Kidney cancer","author":"Wallen","year":"2007"},{"key":"10.1097\/IGC.0b013e3182959053_bb0095","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijrobp.2009.07.1692","article-title":"A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations","volume":"78","author":"Brown","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1097\/IGC.0b013e3182959053_bb0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2307\/3577477","article-title":"Radiation dose and second cancer risk in patients treated for cancer of the cervix","volume":"116","author":"Boice","year":"1988","journal-title":"Radiat Res"},{"key":"10.1097\/IGC.0b013e3182959053_bb0105","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/1097-0142(19950801)76:3<442::AID-CNCR2820760315>3.0.CO;2-L","article-title":"Second primary cancer after treatment for cervical cancer","volume":"76","author":"Kleinerman","year":"1995","journal-title":"Cancer"},{"key":"10.1097\/IGC.0b013e3182959053_bb0110","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJM199902043400504","article-title":"Risk of leukemia after platinum-based chemotherapy for ovarian cancer","volume":"340","author":"Travis","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1097\/IGC.0b013e3182959053_bb0115","first-page":"288\u00c2","article-title":"NCI SEER public-use data: applications and limitations in oncology research","volume":"23","author":"Yu","year":"2009","journal-title":"Oncology (Williston Park)"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24087450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24087450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:18:51Z","timestamp":1753233531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24087450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1048891X24087450"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e3182959053","relation":{},"ISSN":["1048-891X"],"issn-type":[{"type":"print","value":"1048-891X"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Risk of Subsequent Malignancies in Women With Uterine Papillary Serous or Clear Cell Endometrial Cancers","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e3182959053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2013 by IGCS and ESGO.","name":"copyright","label":"Copyright"}]}}